Divisadero Street Capital Management’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
Divisadero Street Capital Management's INDV Position: Q2 2026 in Review
Divisadero Street Capital Management increased its Indivior Pharmaceuticals (INDV) stake by 16% in Q2 2026, buying an estimated $2.93M and bringing the position to 601,863 shares worth $24.7M. The position accounts for 0.56% of the portfolio, ranked #39.
Divisadero Street Capital Management first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. The position peaked at $99.9M in Q4 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- Divisadero Street Capital Management held 601,863 shares of Indivior Pharmaceuticals worth $24.7M as of Q2 2026.
- Divisadero Street Capital Management bought 80,780 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.93M.
- Indivior Pharmaceuticals made up 0.56% of Divisadero Street Capital Management's portfolio in Q2 2026, its #39 holding.
- Divisadero Street Capital Management first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Divisadero Street Capital Management's Indivior Pharmaceuticals position peaked at $99.9M in Q4 2025.
- 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on Divisadero Street Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.